Early Molecular Response to Imatinib Mesylate Predicts Long-Term Outcomes in CML Patients in A Postgraduate Research Institute — A single center Study. (2024). The Planet, 7(01), 255-266. https://bdjournals.org/index.php/planet/article/view/427